61 results
Page 2 of 4
8-K
EX-99.1
eyw6uv737pii
12 May 23
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter
5:20pm
8-K
EX-99.1
xyfe4oxz0zgb2t
5 May 23
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
8d93w3 i6fko4t5moo
11 Oct 22
GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology
6:07am
8-K
EX-99.1
z9yrifmoll9fag2
31 Aug 22
Results of Operations and Financial Condition
4:15pm
8-K
EX-99.1
2xyqjn7 jw7qqzx77
16 Jun 22
GBS Inc. Enters into Exclusivity Agreement for an Acquisition of
5:46pm
DEF 14A
b7awunpdql3o
5 May 22
Definitive proxy
9:58pm
PRE 14A
h0gn4w t4f5cqijoxili
26 Apr 22
Preliminary proxy
4:30pm
8-K
EX-99.1
u9ytel8gkkno0vvv6al
17 Nov 21
GBS Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights
4:05pm
8-K
EX-99.1
yu1923e po2t3vvjn
3 Nov 21
GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing
5:01pm
8-K
dyrnf439h5q
3 Nov 21
GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing
5:01pm
8-K
EX-99.1
w4iaq1q38j6
14 Oct 21
GBS Inc. Announces its Pre-Submission package is with the FDA
12:00pm
10-K
jzn ydo5y
16 Sep 21
Annual report
12:00am
8-K
EX-99.1
q8l 7eov5hp0huc5
11 Aug 21
GBS Inc. Reports Fourth Quarter and Full Year 2021 Preliminary Financial Results and Recent Business Highlights
4:00pm